Finance

Lists
Why is ENTX down 3.42%?
Dive Deeper
ENTX:NASDAQ
Entera Bio Ltd
$3.11
-3.42%
(-0.11) 1D
$3.11
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
$3.22
High
$3.26
Low
$3.08
Mkt. cap
541.57M
Avg. vol.
499.19K
Volume
155.35K
52-wk high
$4.20
52-wk low
$0.91
EPS
-$0.39
Beta
1.48
Shares outstanding
174.14M
No. of employees
27
Open
$3.22
High
$3.26
Low
$3.08
Mkt. cap
541.57M
Avg. vol.
499.19K
Volume
155.35K
52-wk high
$4.20
52-wk low
$0.91
EPS
-$0.39
Beta
1.48
Shares outstanding
174.14M
No. of employees
27
News stories
From web sources and news partners
About Entera Bio Ltd
CEO-
Employees27
Founded2009
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteenterabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current $3.11
$11.00 (+253.70%)
Average
$10.00 (+221.54%)
Lowest
$9.00 (+189.39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Maintained
$11.00
+253.7%
11/09/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$10.00
+221.5%
10/14/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
$9.00
+189.4%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$9.00
+189.4%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.72M
2.25M
3.20M
4.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.32M
1.29M
1.36M
2.34M
Operating expense
3.04M
3.54M
4.56M
7.26M
Total operating expenses
3.04M
3.54M
4.56M
7.26M
Operating income
-3.04M
-3.54M
-4.56M
-7.26M
Other non operating income
-
-
-
-
EBT including unusual items
-3.02M
-3.50M
-7.31M
-15.60M
EBT excluding unusual items
-3.02M
-3.50M
-7.31M
-15.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.02M
-3.50M
-7.31M
-15.60M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
26.00K
34.00K
-
-
Interest expense
-
-
-2.75M
-8.33M
Net interest expenses
26.00K
34.00K
-2.75M
-8.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.04M
-3.53M
-4.55M
-7.26M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps